Asia Pacific Finance Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific Finance Daily.

Press releases published on April 2, 2026

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 mars 2026
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
OceanFirst Financial Corp. Schedules Earnings Conference Call
Dime To Transfer To New York Stock Exchange
Regeneron Collaborates with TriNetX to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions
Business First Bancshares, Inc. Completes $85.0 Million Private Placement of Subordinated Notes
Alerus Financial Corporation to Announce First Quarter Financial Results on Wednesday, April 29
American Assets Trust, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Information
Exodus to Host Inaugural Shareholder Day, The Exodus Summit on May 1 in Omaha
KBR’s Mission Technology Solutions Supports NASA’s Artemis II Mission as Astronauts Embark on Historic Return to the Moon
Riot Announces First Quarter 2026 Production and Operations Updates
AOI Receives New Upsized Order for 800G Data Center Transceivers from Major Hyperscale Customer
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share
Safe Bulkers, Inc. Declares Quarterly Dividend on its 8.00% Series C Cumulative Redeemable Perpetual Preferred Shares; 8.00% Series D Cumulative Redeemable Perpetual Preferred Shares
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Athyrium Capital Management and Esperion Enter Into $50 Million Japan Royalty Financing to Support Strategic Acquisition of Corstasis Therapeutics
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Share this page:

Sign up for:

Asia Pacific Finance Daily

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.